Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference157 articles.
1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2018
2. Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy;Sakamoto;Rev. Recent Clin. Trials,2008
3. Advances in immune checkpoint inhibitors for bone sarcoma therapy;Thanindratarn;Journal of bone oncology,2019
4. Unusual abdominal metastases in osteosarcoma;Berhe;Journal of pediatric surgery case reports,2018
5. miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo;Chen;FEBS Lett.,2019
Cited by 211 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The generation and use of animal models of osteosarcoma in cancer research;Genes & Diseases;2024-03
2. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma;Medicine;2024-02-02
3. Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis;Nano Today;2024-02
4. LINC00960 affects osteosarcoma treatment and prognosis by regulating the tumor immune microenvironment;Heliyon;2024-02
5. Atualização sobre osteossarcoma convencional;Revista Brasileira de Ortopedia;2024-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3